Venture
BlossomHill Therapeutics, Inc.
Latest Form D 2025-12-10- CIK 1839970
- State CA
- Pharmaceuticals
- 4 Form D offerings since 2021-01-11
- Total sold
- $246M
- across 4 offerings
- Rounds
- 4
- Form D offerings since 2021-01-11
- Latest round
- $84.2M
- 2025-12-10 · 021-566357
- Investors
- 47
- on the latest round
Connected
named in its Form D filingsOfferings · since 2021-01-114 Form D offeringsExemptions506(b)People · Item 3JINGRONG JEAN CUI + 6 moreInvestors · dashboardInferred investors
BlossomHill Therapeutics, Inc.CIK 1839970
Round timeline
amount sold · by first filed2025-12-10 · $84.2M
- 2021-01-11$2M021-385888
- 2021-03-01$71M021-390805
- 2024-01-02$88.6M021-501240
- 2025-12-10$84.2M021-566357
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($88.6M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-566357 | First filed2025-12-10 | Latest2025-12-10 | Sought$84.2M | Sold$84.2M | Investors47 | Exemptions506(b) |
| 021-501240 | First filed2024-01-02 | Latest2024-01-02 | Sought$100M | Sold$88.6M | Investors44 | Exemptions506(b) |
| 021-390805 | First filed2021-03-01 | Latest2021-03-01 | Sought$71M | Sold$71M | Investors27 | Exemptions506(b) |
| 021-385888 | First filed2021-01-11 | Latest2021-01-11 | Sought$2M | Sold$2M | Investors3 | Exemptions506(b) |
Who backs BlossomHill Therapeutics, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2025-12-10
| Name | Relationship |
|---|---|
| JINGRONG JEAN CUI | RelationshipExecutive Officer, Director |
| YISHAN LI | RelationshipExecutive Officer, Director |
| GEORGE LEE | RelationshipDirector |
| BIHUA CHEN | RelationshipDirector |
| CARL GORDON | RelationshipDirector |
| SUNDEEP AGRAWAL | RelationshipDirector |
| TIMOTHY STUBBS | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Pharmaceuticals
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-01-11
- Latest filing
- 2025-12-10
Who backs BlossomHill Therapeutics, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗